Fecal levels of scfa and bcfa during capecitabine in patients with metastatic or unresectable colorectal cancer

HIGHLIGHTS

• who: Janine Ziemons from the MUMC+ Maastricht University Medical Center have published the article: Fecal levels of SCFA and BCFA during capecitabine in patients with metastatic or unresectable colorectal cancer, in the Journal: Nutritional status, physical performance and the prevalence of chemotherapyu2011induced toxicity during three cycles of capecitabine During three cycles of capecitabine, the risk for malnutrition (MUST score) did not change significantly in the current study population (p=0.127) (Table S3). KPS scores, which are patient-reported measures of physical performance status, decreased significantly at T2 (median=80, IQR=20, p=0.02) and T3 . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.